3-Hydroxy-isobutyryl-CoA  ||| S:0 E:25 ||| NNP
hydrolase  ||| S:25 E:35 ||| JJ
deficiency  ||| S:35 E:46 ||| NN
in  ||| S:46 E:49 ||| IN
a  ||| S:49 E:51 ||| DT
child  ||| S:51 E:57 ||| NN
with  ||| S:57 E:62 ||| IN
Leigh-like  ||| S:62 E:73 ||| JJ
syndrome  ||| S:73 E:82 ||| NN
and  ||| S:82 E:86 ||| CC
literature  ||| S:86 E:97 ||| NN
review  ||| S:97 E:104 ||| NN
To  ||| S:104 E:107 ||| TO
investigate  ||| S:107 E:119 ||| VB
the  ||| S:119 E:123 ||| DT
clinical  ||| S:123 E:132 ||| JJ
features  ||| S:132 E:141 ||| NNS
and  ||| S:141 E:145 ||| CC
genetic  ||| S:145 E:153 ||| JJ
characteristics  ||| S:153 E:169 ||| NNS
of  ||| S:169 E:172 ||| IN
patients  ||| S:172 E:181 ||| NNS
with  ||| S:181 E:186 ||| IN
3-hydroxy-isobutyryl-CoA  ||| S:186 E:211 ||| CD
hydrolase  ||| S:211 E:221 ||| NNS
( ||| S:221 E:222 ||| -LRB-
HIBCH ||| S:222 E:227 ||| NNP
)  ||| S:227 E:229 ||| -RRB-
gene  ||| S:229 E:234 ||| NN
mutations ||| S:234 E:243 ||| NNS
.  ||| S:243 E:245 ||| .
The  ||| S:245 E:249 ||| DT
clinical  ||| S:249 E:258 ||| JJ
data  ||| S:258 E:263 ||| NNS
of  ||| S:263 E:266 ||| IN
a  ||| S:266 E:268 ||| DT
patient  ||| S:268 E:276 ||| NN
with  ||| S:276 E:281 ||| IN
novel  ||| S:281 E:287 ||| NN
HIBCH  ||| S:287 E:293 ||| NN
mutations  ||| S:293 E:303 ||| NNS
were  ||| S:303 E:308 ||| VBD
collected ||| S:308 E:317 ||| VBN
,  ||| S:317 E:319 ||| ,
the  ||| S:319 E:323 ||| DT
related  ||| S:323 E:331 ||| JJ
literature  ||| S:331 E:342 ||| NN
was  ||| S:342 E:346 ||| VBD
searched  ||| S:346 E:355 ||| VBN
from  ||| S:355 E:360 ||| IN
China  ||| S:360 E:366 ||| NNP
National  ||| S:366 E:375 ||| NNP
Knowledge  ||| S:375 E:385 ||| NNP
Infrastructure ||| S:385 E:399 ||| NNP
,  ||| S:399 E:401 ||| ,
Wanfang  ||| S:401 E:409 ||| NNP
Data  ||| S:409 E:414 ||| NNP
Knowledge  ||| S:414 E:424 ||| NNP
Service  ||| S:424 E:432 ||| NNP
Platform ||| S:432 E:440 ||| NNP
,  ||| S:440 E:442 ||| ,
National  ||| S:442 E:451 ||| NNP
Center  ||| S:451 E:458 ||| NNP
for  ||| S:458 E:462 ||| IN
Biotechnology  ||| S:462 E:476 ||| NNP
Information  ||| S:476 E:488 ||| NNP
and  ||| S:488 E:492 ||| CC
PubMed  ||| S:492 E:499 ||| NNP
( ||| S:499 E:500 ||| -LRB-
up  ||| S:500 E:503 ||| RB
to  ||| S:503 E:506 ||| TO
December  ||| S:506 E:515 ||| NNP
2014 ||| S:515 E:519 ||| CD
)  ||| S:519 E:521 ||| -RRB-
by  ||| S:521 E:524 ||| IN
using  ||| S:524 E:530 ||| VBG
search  ||| S:530 E:537 ||| NN
terms  ||| S:537 E:543 ||| NNS
HIBCH ||| S:543 E:548 ||| NNP
,  ||| S:548 E:550 ||| ,
3-hydroxy-isobutyryl-CoA  ||| S:550 E:575 ||| CD
hydrolase  ||| S:575 E:585 ||| NNS
or  ||| S:585 E:588 ||| CC
beta-Hydroxyisobutyryl  ||| S:588 E:611 ||| NNP
CoA  ||| S:611 E:615 ||| NNP
Deacylase  ||| S:615 E:625 ||| NNP
Deficiency ||| S:625 E:635 ||| NNP
.  ||| S:635 E:637 ||| .
The  ||| S:637 E:641 ||| DT
clinical  ||| S:641 E:650 ||| JJ
features ||| S:650 E:658 ||| NNS
,  ||| S:658 E:660 ||| ,
neuroimage  ||| S:660 E:671 ||| NN
and  ||| S:671 E:675 ||| CC
treatment  ||| S:675 E:685 ||| NN
of  ||| S:685 E:688 ||| IN
the  ||| S:688 E:692 ||| DT
patients  ||| S:692 E:701 ||| NNS
with  ||| S:701 E:706 ||| IN
HIBCH  ||| S:706 E:712 ||| NNP
gene  ||| S:712 E:717 ||| NN
mutations  ||| S:717 E:727 ||| NNS
were  ||| S:727 E:732 ||| VBD
studied ||| S:732 E:739 ||| VBN
.  ||| S:739 E:741 ||| .
The  ||| S:741 E:745 ||| DT
patient  ||| S:745 E:753 ||| NN
was  ||| S:753 E:757 ||| VBD
a  ||| S:757 E:759 ||| DT
girl  ||| S:759 E:764 ||| NN
who  ||| S:764 E:768 ||| WP
was  ||| S:768 E:772 ||| VBD
born  ||| S:772 E:777 ||| VBN
at  ||| S:777 E:780 ||| IN
term  ||| S:780 E:785 ||| NN
after  ||| S:785 E:791 ||| IN
an  ||| S:791 E:794 ||| DT
uneventful  ||| S:794 E:805 ||| JJ
pregnancy  ||| S:805 E:815 ||| NN
to  ||| S:815 E:818 ||| TO
non-consanguineous  ||| S:818 E:837 ||| JJ
healthy  ||| S:837 E:845 ||| JJ
parents ||| S:845 E:852 ||| NNS
,  ||| S:852 E:854 ||| ,
she  ||| S:854 E:858 ||| PRP
was  ||| S:858 E:862 ||| VBD
hospitalized  ||| S:862 E:875 ||| VBN
at  ||| S:875 E:878 ||| IN
5  ||| S:878 E:880 ||| CD
years  ||| S:880 E:886 ||| NNS
and  ||| S:886 E:890 ||| CC
5  ||| S:890 E:892 ||| CD
months  ||| S:892 E:899 ||| NNS
of  ||| S:899 E:902 ||| IN
age  ||| S:902 E:906 ||| NN
because  ||| S:906 E:914 ||| IN
of  ||| S:914 E:917 ||| IN
development  ||| S:917 E:929 ||| NN
delay  ||| S:929 E:935 ||| NN
for  ||| S:935 E:939 ||| IN
5  ||| S:939 E:941 ||| CD
years  ||| S:941 E:947 ||| NNS
and  ||| S:947 E:951 ||| CC
5  ||| S:951 E:953 ||| CD
months  ||| S:953 E:960 ||| NNS
and  ||| S:960 E:964 ||| CC
abnormal  ||| S:964 E:973 ||| JJ
posture  ||| S:973 E:981 ||| NN
on  ||| S:981 E:984 ||| IN
the  ||| S:984 E:988 ||| DT
left  ||| S:988 E:993 ||| VBN
of  ||| S:993 E:996 ||| IN
body  ||| S:996 E:1001 ||| NN
for  ||| S:1001 E:1005 ||| IN
more  ||| S:1005 E:1010 ||| JJR
than  ||| S:1010 E:1015 ||| IN
10  ||| S:1015 E:1018 ||| CD
days ||| S:1018 E:1022 ||| NNS
.  ||| S:1022 E:1024 ||| .
The  ||| S:1024 E:1028 ||| DT
family  ||| S:1028 E:1035 ||| NN
history  ||| S:1035 E:1043 ||| NN
was  ||| S:1043 E:1047 ||| VBD
unremarkable ||| S:1047 E:1059 ||| VBN
.  ||| S:1059 E:1061 ||| .
Her  ||| S:1061 E:1065 ||| PRP$
psychomotor  ||| S:1065 E:1077 ||| JJ
development  ||| S:1077 E:1089 ||| NN
was  ||| S:1089 E:1093 ||| VBD
significantly  ||| S:1093 E:1107 ||| RB
delayed ||| S:1107 E:1114 ||| VBN
.  ||| S:1114 E:1116 ||| .
Three  ||| S:1116 E:1122 ||| CD
times  ||| S:1122 E:1128 ||| NNS
brain  ||| S:1128 E:1134 ||| NN
MRI  ||| S:1134 E:1138 ||| NNP
between  ||| S:1138 E:1146 ||| IN
2.  ||| S:1146 E:1149 ||| CD
5  ||| S:1149 E:1151 ||| CD
years  ||| S:1151 E:1157 ||| NNS
and  ||| S:1157 E:1161 ||| CC
5  ||| S:1161 E:1163 ||| CD
years  ||| S:1163 E:1169 ||| NNS
of  ||| S:1169 E:1172 ||| IN
age  ||| S:1172 E:1176 ||| NN
revealed  ||| S:1176 E:1185 ||| VBD
bilateral  ||| S:1185 E:1195 ||| JJ
symmetrical  ||| S:1195 E:1207 ||| JJ
lesions  ||| S:1207 E:1215 ||| NNS
in  ||| S:1215 E:1218 ||| IN
basal  ||| S:1218 E:1224 ||| JJ
ganglia ||| S:1224 E:1231 ||| NN
.  ||| S:1231 E:1233 ||| .
At  ||| S:1233 E:1236 ||| IN
the  ||| S:1236 E:1240 ||| DT
age  ||| S:1240 E:1244 ||| NN
of  ||| S:1244 E:1247 ||| IN
5  ||| S:1247 E:1249 ||| CD
years  ||| S:1249 E:1255 ||| NNS
and  ||| S:1255 E:1259 ||| CC
5  ||| S:1259 E:1261 ||| CD
months ||| S:1261 E:1267 ||| NNS
,  ||| S:1267 E:1269 ||| ,
she  ||| S:1269 E:1273 ||| PRP
presented  ||| S:1273 E:1283 ||| VBD
with  ||| S:1283 E:1288 ||| IN
acute  ||| S:1288 E:1294 ||| JJ
encephalopathy  ||| S:1294 E:1309 ||| NN
and  ||| S:1309 E:1313 ||| CC
severe  ||| S:1313 E:1320 ||| JJ
extrapyramidal  ||| S:1320 E:1335 ||| JJ
symptoms  ||| S:1335 E:1344 ||| NNS
preceded  ||| S:1344 E:1353 ||| VBN
by  ||| S:1353 E:1356 ||| IN
fever ||| S:1356 E:1361 ||| NN
.  ||| S:1361 E:1363 ||| .
At  ||| S:1363 E:1366 ||| IN
that  ||| S:1366 E:1371 ||| DT
time ||| S:1371 E:1375 ||| NN
,  ||| S:1375 E:1377 ||| ,
her  ||| S:1377 E:1381 ||| PRP$
brain  ||| S:1381 E:1387 ||| NN
MRI  ||| S:1387 E:1391 ||| NNP
revealed  ||| S:1391 E:1400 ||| VBD
aggravated  ||| S:1400 E:1411 ||| VBN
lesions  ||| S:1411 E:1419 ||| NNS
in  ||| S:1419 E:1422 ||| IN
bilateral  ||| S:1422 E:1432 ||| JJ
basal  ||| S:1432 E:1438 ||| JJ
ganglia ||| S:1438 E:1445 ||| NN
,  ||| S:1445 E:1447 ||| ,
new  ||| S:1447 E:1451 ||| JJ
lesions  ||| S:1451 E:1459 ||| NNS
in  ||| S:1459 E:1462 ||| IN
the  ||| S:1462 E:1466 ||| DT
midbrain  ||| S:1466 E:1475 ||| JJ
cerebral  ||| S:1475 E:1484 ||| JJ
peduncle  ||| S:1484 E:1493 ||| NN
and  ||| S:1493 E:1497 ||| CC
pons ||| S:1497 E:1501 ||| NN
,  ||| S:1501 E:1503 ||| ,
and  ||| S:1503 E:1507 ||| CC
cerebellar  ||| S:1507 E:1518 ||| JJ
atrophy ||| S:1518 E:1525 ||| NN
.  ||| S:1525 E:1527 ||| .
The  ||| S:1527 E:1531 ||| DT
results  ||| S:1531 E:1539 ||| NNS
of  ||| S:1539 E:1542 ||| IN
biochemical  ||| S:1542 E:1554 ||| JJ
tests  ||| S:1554 E:1560 ||| NNS
were  ||| S:1560 E:1565 ||| VBD
normal ||| S:1565 E:1571 ||| JJ
.  ||| S:1571 E:1573 ||| .
A  ||| S:1573 E:1575 ||| DT
novel  ||| S:1575 E:1581 ||| NN
compound  ||| S:1581 E:1590 ||| NN
heterozygous  ||| S:1590 E:1603 ||| NN
mutation  ||| S:1603 E:1612 ||| NN
of  ||| S:1612 E:1615 ||| IN
HIBCH  ||| S:1615 E:1621 ||| NNP
gene ||| S:1621 E:1625 ||| NN
,  ||| S:1625 E:1627 ||| ,
c.  ||| S:1627 E:1630 ||| NNP
1027C  ||| S:1630 E:1636 ||| NNP
>  ||| S:1636 E:1638 ||| NNP
G ||| S:1638 E:1639 ||| NNP
,  ||| S:1639 E:1641 ||| ,
p ||| S:1641 E:1642 ||| NN
.  ||| S:1642 E:1644 ||| .
H343D  ||| S:1644 E:1650 ||| NNP
and  ||| S:1650 E:1654 ||| CC
c.  ||| S:1654 E:1657 ||| CD
79-1G  ||| S:1657 E:1663 ||| CD
>  ||| S:1663 E:1665 ||| CD
T ||| S:1665 E:1666 ||| NN
,  ||| S:1666 E:1668 ||| ,
splicing ||| S:1668 E:1676 ||| NN
,  ||| S:1676 E:1678 ||| ,
were  ||| S:1678 E:1683 ||| VBD
found  ||| S:1683 E:1689 ||| VBN
in  ||| S:1689 E:1692 ||| IN
the  ||| S:1692 E:1696 ||| DT
parent ||| S:1696 E:1702 ||| NN
.  ||| S:1702 E:1704 ||| .
Further  ||| S:1704 E:1712 ||| JJ
study  ||| S:1712 E:1718 ||| NN
showed  ||| S:1718 E:1725 ||| VBD
that  ||| S:1725 E:1730 ||| IN
c.  ||| S:1730 E:1733 ||| CD
1027  ||| S:1733 E:1738 ||| CD
C  ||| S:1738 E:1740 ||| NNP
>  ||| S:1740 E:1742 ||| NNP
G  ||| S:1742 E:1744 ||| NNP
mutation  ||| S:1744 E:1753 ||| NN
was  ||| S:1753 E:1757 ||| VBD
inherited  ||| S:1757 E:1767 ||| VBN
from  ||| S:1767 E:1772 ||| IN
her  ||| S:1772 E:1776 ||| PRP$
father  ||| S:1776 E:1783 ||| NN
and  ||| S:1783 E:1787 ||| CC
c.  ||| S:1787 E:1790 ||| NNP
79-1  ||| S:1790 E:1795 ||| NNP
G  ||| S:1795 E:1797 ||| NNP
>  ||| S:1797 E:1799 ||| NNP
T  ||| S:1799 E:1801 ||| NN
from  ||| S:1801 E:1806 ||| IN
her  ||| S:1806 E:1810 ||| PRP$
mother ||| S:1810 E:1816 ||| NN
.  ||| S:1816 E:1818 ||| .
Her  ||| S:1818 E:1822 ||| PRP$
symptoms  ||| S:1822 E:1831 ||| NNS
were  ||| S:1831 E:1836 ||| VBD
mitigated  ||| S:1836 E:1846 ||| VBN
after  ||| S:1846 E:1852 ||| IN
cocktail  ||| S:1852 E:1861 ||| JJ
therapy  ||| S:1861 E:1869 ||| NN
and  ||| S:1869 E:1873 ||| CC
symptomatic  ||| S:1873 E:1885 ||| JJ
treatment ||| S:1885 E:1894 ||| NN
.  ||| S:1894 E:1896 ||| .
Repeated  ||| S:1896 E:1905 ||| JJ
brain  ||| S:1905 E:1911 ||| NN
MRI  ||| S:1911 E:1915 ||| NNP
revealed  ||| S:1915 E:1924 ||| VBD
that  ||| S:1924 E:1929 ||| IN
the  ||| S:1929 E:1933 ||| DT
lesion  ||| S:1933 E:1940 ||| NN
in  ||| S:1940 E:1943 ||| IN
basal  ||| S:1943 E:1949 ||| JJ
ganglia  ||| S:1949 E:1957 ||| NN
got  ||| S:1957 E:1961 ||| VBD
better ||| S:1961 E:1967 ||| JJR
,  ||| S:1967 E:1969 ||| ,
the  ||| S:1969 E:1973 ||| DT
lesions  ||| S:1973 E:1981 ||| NN
in  ||| S:1981 E:1984 ||| IN
brain  ||| S:1984 E:1990 ||| NN
stem  ||| S:1990 E:1995 ||| NN
disappeared ||| S:1995 E:2006 ||| VBD
.  ||| S:2006 E:2008 ||| .
Literature  ||| S:2008 E:2019 ||| JJ
relevant  ||| S:2019 E:2028 ||| JJ
to  ||| S:2028 E:2031 ||| TO
HIBCH  ||| S:2031 E:2037 ||| NNP
published  ||| S:2037 E:2047 ||| VBD
all  ||| S:2047 E:2051 ||| DT
around  ||| S:2051 E:2058 ||| IN
the  ||| S:2058 E:2062 ||| DT
world  ||| S:2062 E:2068 ||| NN
was  ||| S:2068 E:2072 ||| VBD
reviewed ||| S:2072 E:2080 ||| VBN
,  ||| S:2080 E:2082 ||| ,
no  ||| S:2082 E:2085 ||| DT
Chinese  ||| S:2085 E:2093 ||| JJ
cases  ||| S:2093 E:2099 ||| NNS
with  ||| S:2099 E:2104 ||| IN
HIBCH  ||| S:2104 E:2110 ||| NNP
gene  ||| S:2110 E:2115 ||| NN
mutations  ||| S:2115 E:2125 ||| NNS
had  ||| S:2125 E:2129 ||| VBD
been  ||| S:2129 E:2134 ||| VBN
reported ||| S:2134 E:2142 ||| VBN
,  ||| S:2142 E:2144 ||| ,
6  ||| S:2144 E:2146 ||| CD
foreign  ||| S:2146 E:2154 ||| JJ
cases  ||| S:2154 E:2160 ||| NNS
with  ||| S:2160 E:2165 ||| IN
HIBCH  ||| S:2165 E:2171 ||| NNP
gene  ||| S:2171 E:2176 ||| NN
mutations  ||| S:2176 E:2186 ||| NNS
were  ||| S:2186 E:2191 ||| VBD
reported ||| S:2191 E:2199 ||| VBN
.  ||| S:2199 E:2201 ||| .
Among  ||| S:2201 E:2207 ||| IN
them ||| S:2207 E:2211 ||| PRP
,  ||| S:2211 E:2213 ||| ,
5  ||| S:2213 E:2215 ||| CD
patients  ||| S:2215 E:2224 ||| NNS
were  ||| S:2224 E:2229 ||| VBD
diagnosed  ||| S:2229 E:2239 ||| VBN
as  ||| S:2239 E:2242 ||| IN
Leigh-like  ||| S:2242 E:2253 ||| JJ
syndrome ||| S:2253 E:2261 ||| NN
,  ||| S:2261 E:2263 ||| ,
with  ||| S:2263 E:2268 ||| IN
progressive  ||| S:2268 E:2280 ||| JJ
neurodegenerative  ||| S:2280 E:2298 ||| JJ
course ||| S:2298 E:2304 ||| NN
,  ||| S:2304 E:2306 ||| ,
and  ||| S:2306 E:2310 ||| CC
symmetrical  ||| S:2310 E:2322 ||| JJ
basal  ||| S:2322 E:2328 ||| JJ
ganglia  ||| S:2328 E:2336 ||| JJ
lesions  ||| S:2336 E:2344 ||| NNS
on  ||| S:2344 E:2347 ||| IN
brain  ||| S:2347 E:2353 ||| NN
MRI ||| S:2353 E:2356 ||| NNP
.  ||| S:2356 E:2358 ||| .
Another  ||| S:2358 E:2366 ||| DT
case  ||| S:2366 E:2371 ||| NN
was  ||| S:2371 E:2375 ||| VBD
reported  ||| S:2375 E:2384 ||| VBN
in  ||| S:2384 E:2387 ||| IN
1982 ||| S:2387 E:2391 ||| CD
,  ||| S:2391 E:2393 ||| ,
with  ||| S:2393 E:2398 ||| IN
developmental  ||| S:2398 E:2412 ||| JJ
delay  ||| S:2412 E:2418 ||| NN
and  ||| S:2418 E:2422 ||| CC
various  ||| S:2422 E:2430 ||| JJ
physical  ||| S:2430 E:2439 ||| JJ
malformations  ||| S:2439 E:2453 ||| NN
without  ||| S:2453 E:2461 ||| IN
data  ||| S:2461 E:2466 ||| NNS
on  ||| S:2466 E:2469 ||| IN
his  ||| S:2469 E:2473 ||| PRP$
brain  ||| S:2473 E:2479 ||| NN
MRI ||| S:2479 E:2482 ||| NNP
.  ||| S:2482 E:2484 ||| .
HIBCH  ||| S:2484 E:2490 ||| NNP
gene  ||| S:2490 E:2495 ||| NN
mutational  ||| S:2495 E:2506 ||| NN
analysis  ||| S:2506 E:2515 ||| NN
showed  ||| S:2515 E:2522 ||| VBD
that  ||| S:2522 E:2527 ||| IN
4  ||| S:2527 E:2529 ||| CD
cases  ||| S:2529 E:2535 ||| NNS
had  ||| S:2535 E:2539 ||| VBD
homozygous  ||| S:2539 E:2550 ||| JJ
mutations ||| S:2550 E:2559 ||| NNS
,  ||| S:2559 E:2561 ||| ,
which  ||| S:2561 E:2567 ||| WDT
were  ||| S:2567 E:2572 ||| VBD
c.  ||| S:2572 E:2575 ||| CD
950G  ||| S:2575 E:2580 ||| CD
>  ||| S:2580 E:2582 ||| CD
A  ||| S:2582 E:2584 ||| DT
( ||| S:2584 E:2585 ||| -LRB-
p ||| S:2585 E:2586 ||| NN
.  ||| S:2586 E:2588 ||| .
G317E ||| S:2588 E:2593 ||| NNP
)  ||| S:2593 E:2595 ||| -RRB-
in  ||| S:2595 E:2598 ||| IN
two  ||| S:2598 E:2602 ||| CD
brothers ||| S:2602 E:2610 ||| NNS
,  ||| S:2610 E:2612 ||| ,
c.  ||| S:2612 E:2615 ||| CD
219  ||| S:2615 E:2619 ||| CD
_220insTTGAATAG  ||| S:2619 E:2635 ||| CD
( ||| S:2635 E:2636 ||| -LRB-
p ||| S:2636 E:2637 ||| NN
.  ||| S:2637 E:2639 ||| .
K73fsX86 ||| S:2639 E:2647 ||| NNP
)  ||| S:2647 E:2649 ||| -RRB-
and  ||| S:2649 E:2653 ||| CC
c.  ||| S:2653 E:2656 ||| NNP
1128_1129insT  ||| S:2656 E:2670 ||| NNP
( ||| S:2670 E:2671 ||| -LRB-
p ||| S:2671 E:2672 ||| NN
.  ||| S:2672 E:2674 ||| .
K377X ||| S:2674 E:2679 ||| NNP
)  ||| S:2679 E:2681 ||| -RRB-
respectively ||| S:2681 E:2693 ||| RB
.  ||| S:2693 E:2695 ||| .
Three  ||| S:2695 E:2701 ||| CD
of  ||| S:2701 E:2704 ||| IN
them  ||| S:2704 E:2709 ||| PRP
died  ||| S:2709 E:2714 ||| VBD
before  ||| S:2714 E:2721 ||| IN
3  ||| S:2721 E:2723 ||| CD
years  ||| S:2723 E:2729 ||| NNS
old ||| S:2729 E:2732 ||| JJ
.  ||| S:2732 E:2734 ||| .
Two  ||| S:2734 E:2738 ||| CD
cases  ||| S:2738 E:2744 ||| NNS
had  ||| S:2744 E:2748 ||| VBD
compound  ||| S:2748 E:2757 ||| JJ
heterozygous  ||| S:2757 E:2770 ||| JJ
mutations ||| S:2770 E:2779 ||| NNS
:  ||| S:2779 E:2781 ||| :
c.  ||| S:2781 E:2784 ||| NNP
365A  ||| S:2784 E:2789 ||| NNP
>  ||| S:2789 E:2791 ||| NNP
G  ||| S:2791 E:2793 ||| NNP
( ||| S:2793 E:2794 ||| -LRB-
p ||| S:2794 E:2795 ||| NN
.  ||| S:2795 E:2797 ||| .
Y122C ||| S:2797 E:2802 ||| NNP
)  ||| S:2802 E:2804 ||| -RRB-
and  ||| S:2804 E:2808 ||| CC
IVS2-3C  ||| S:2808 E:2816 ||| NNP
>  ||| S:2816 E:2818 ||| NNP
G  ||| S:2818 E:2820 ||| NNP
( ||| S:2820 E:2821 ||| -LRB-
p ||| S:2821 E:2822 ||| NN
.  ||| S:2822 E:2824 ||| .
R27fsX50 ||| S:2824 E:2832 ||| NNP
) ||| S:2832 E:2833 ||| -RRB-
;  ||| S:2833 E:2835 ||| :
c.  ||| S:2835 E:2838 ||| CD
517  ||| S:2838 E:2842 ||| CD
+  ||| S:2842 E:2844 ||| CD
1G  ||| S:2844 E:2847 ||| CD
>  ||| S:2847 E:2849 ||| CD
A  ||| S:2849 E:2851 ||| NN
and  ||| S:2851 E:2855 ||| CC
c.  ||| S:2855 E:2858 ||| CD
410C  ||| S:2858 E:2863 ||| CD
>  ||| S:2863 E:2865 ||| CD
T  ||| S:2865 E:2867 ||| NN
( ||| S:2867 E:2868 ||| -LRB-
p ||| S:2868 E:2869 ||| NN
.  ||| S:2869 E:2871 ||| .
A137V ||| S:2871 E:2876 ||| NNP
) ||| S:2876 E:2877 ||| -RRB-
.  ||| S:2877 E:2879 ||| .
They  ||| S:2879 E:2884 ||| PRP
were  ||| S:2884 E:2889 ||| VBD
alive  ||| S:2889 E:2895 ||| JJ
at  ||| S:2895 E:2898 ||| IN
the  ||| S:2898 E:2902 ||| DT
time  ||| S:2902 E:2907 ||| NN
of  ||| S:2907 E:2910 ||| IN
the  ||| S:2910 E:2914 ||| DT
report ||| S:2914 E:2920 ||| NN
.  ||| S:2920 E:2922 ||| .
Patients  ||| S:2922 E:2931 ||| NNS
with  ||| S:2931 E:2936 ||| IN
HIBCH  ||| S:2936 E:2942 ||| NNP
gene  ||| S:2942 E:2947 ||| NN
mutation  ||| S:2947 E:2956 ||| NN
mainly  ||| S:2956 E:2963 ||| RB
presented  ||| S:2963 E:2973 ||| VBN
as  ||| S:2973 E:2976 ||| IN
Leigh-like  ||| S:2976 E:2987 ||| JJ
syndrome  ||| S:2987 E:2996 ||| NN
both  ||| S:2996 E:3001 ||| CC
in  ||| S:3001 E:3004 ||| IN
clinical  ||| S:3004 E:3013 ||| JJ
manifestation  ||| S:3013 E:3027 ||| NN
and  ||| S:3027 E:3031 ||| CC
in  ||| S:3031 E:3034 ||| IN
neuroimage ||| S:3034 E:3044 ||| NN
.  ||| S:3044 E:3046 ||| .
HIBCH  ||| S:3046 E:3052 ||| NNP
gene  ||| S:3052 E:3057 ||| NN
mutational  ||| S:3057 E:3068 ||| NN
analysis  ||| S:3068 E:3077 ||| NN
should  ||| S:3077 E:3084 ||| MD
be  ||| S:3084 E:3087 ||| VB
performed  ||| S:3087 E:3097 ||| VBN
on  ||| S:3097 E:3100 ||| IN
children  ||| S:3100 E:3109 ||| NNS
with  ||| S:3109 E:3114 ||| IN
Leigh-like  ||| S:3114 E:3125 ||| JJ
syndrome ||| S:3125 E:3133 ||| NN
,  ||| S:3133 E:3135 ||| ,
if  ||| S:3135 E:3138 ||| IN
the  ||| S:3138 E:3142 ||| DT
mutations  ||| S:3142 E:3152 ||| NN
of  ||| S:3152 E:3155 ||| IN
known  ||| S:3155 E:3161 ||| JJ
genes  ||| S:3161 E:3167 ||| NNS
of  ||| S:3167 E:3170 ||| IN
Leigh  ||| S:3170 E:3176 ||| NNP
syndrome  ||| S:3176 E:3185 ||| NN
were  ||| S:3185 E:3190 ||| VBD
negative ||| S:3190 E:3198 ||| JJ
.  ||| S:3198 E:3200 ||| .
